Amiram Ariel

Prof. Amiram Ariel

The Department of Human Biology, The Faculty of Natural Sciences, The University of Haifa
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SSSagie Schif‐Zuck
Sagie Schif‐Zuck
NGNufar Gross
Nufar Gross
SASimaan Assi
Simaan Assi
RRRan Rostoker
Ran Rostoker
CSCharles N. Serhan
Charles N. Serhan
AAAmiram Ariel
Amiram Ariel
During the resolution phase of inflammation, apoptotic leukocytes are efferocytosed by macrophages in a nonphlogistic fashion that results in diminished responses to bacterial moieties and production of anti‐inflammatory cytokines. Complement receptor 3 and pro‐resolving lipid mediators promote the engulfment of apoptotic leukocytes by macrophages. Here, we present evidence for the emergence of pro‐resolving, CD11blow macrophages in vivo during the resolution of murine peritonitis. These macrophages are distinct from the majority of peritoneal macrophages in terms of their functional protein expression profile, as well as pro‐resolving properties, such as apoptotic leukocyte engulfment, indifference to TLR ligands, and emigration to lymphoid organs. Notably, we also found macrophages convert from the CD11bhigh to the CD11blow phenotype upon interaction with apoptotic cells ex vivo. In addition, we found that the pro‐resolving lipid mediators resolvin E1 and D1, and the glucocorticoid dexamethasone regulated pro‐resolving macrophage functions in vivo. This regulation culminated in a novel pro‐resolving function, namely reducing the apoptotic leukocyte ingestion requirement for CD11blow macrophage generation. These new phenotype and molecular pathway markers define the new satiated macrophage. Thus, we suggest that satisfying efferocytosis generates CD11blow macrophages that are essential for complete nonphlogistic containment of inflammatory agents and the termination of acute inflammation.

15 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
EKEman Khatib-Massalha
Eman Khatib-Massalha
SBSuditi Bhattacharya
Suditi Bhattacharya
HMHassan Massalha
Hassan Massalha
ABAdi Biram
Adi Biram
KGKarin Golan
Karin Golan
TLTsvee Lapidot
Tsvee Lapidot
Neutrophils provide first line of host defense against bacterial infections utilizing glycolysis for their effector functions. How glycolysis and its major byproduct lactate are triggered in bone marrow (BM) neutrophils and their contribution to neutrophil mobilization in acute inflammation is not clear. Here we report that bacterial lipopolysaccharides (LPS) orSalmonellaTyphimurium triggers lactate release by increasing glycolysis, NADPH-oxidase-mediated reactive oxygen species and HIF-1α levels in BM neutrophils. Increased release of BM lactate preferentially promotes neutrophil mobilization by reducing endothelial VE-Cadherin expression, increasing BM vascular permeability via endothelial lactate-receptor GPR81 signaling. GPR81−/−mice mobilize reduced levels of neutrophils in response to LPS, unless rescued by VE-Cadherin disrupting antibodies. Lactate administration also induces release of the BM neutrophil mobilizers G-CSF, CXCL1 and CXCL2, indicating that this metabolite drives neutrophil mobilization via multiple pathways. Our study reveals a metabolic crosstalk between lactate-producing neutrophils and BM endothelium, which controls neutrophil mobilization under bacterial infection.

2 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Senthil Kumaran SatyanarayananSenthil Kumaran Satyanarayanan
Senthil Kumaran Satyanarayanan
DKDriss El Kebir
Driss El Kebir
SSSoaad Soboh
Soaad Soboh
SBSergei Butenko
Sergei Butenko
MSMeriem Sekheri
Meriem Sekheri
AAAmiram Ariel
Amiram Ariel
The uptake of apoptotic polymorphonuclear cells (PMN) by macrophages is critical for timely resolution of inflammation. High-burden uptake of apoptotic cells is associated with loss of phagocytosis in resolution phase macrophages. Here, using a transcriptomic analysis of macrophage subsets, we show that non-phagocytic resolution phase macrophages express a distinct IFN-β-related gene signature in mice. We also report elevated levels of IFN-β in peritoneal and broncho-alveolar exudates in mice during the resolution of peritonitis and pneumonia, respectively. Elimination of endogenous IFN-β impairs, whereas treatment with exogenous IFN-β enhances, bacterial clearance, PMN apoptosis, efferocytosis and macrophage reprogramming. STAT3 signalling in response to IFN-β promotes apoptosis of human PMNs. Finally, uptake of apoptotic cells promotes loss of phagocytic capacity in macrophages alongside decreased surface expression of efferocytic receptors in vivo. Collectively, these results identify IFN-β produced by resolution phase macrophages as an effector cytokine in resolving bacterial inflammation.

1 January 2012 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AAAmiram Ariel
Amiram Ariel
CSCharles N. Serhan
Charles N. Serhan
Monocytes that migrate into tissues during inflammatory episodes and differentiate to macrophages were previously classified as classically (M1) or alternatively (M2) activated macrophages, based on their exposure to different fate-determining mediators. These macrophage subsets display distinct molecular markers and differential functions. At the same time, studies from recent years found that the encounter of apoptotic leukocytes with macrophages leads to the clearance of this cellular “debris” by the macrophages, while concomitantly reprogramming/immune-silencing the macrophages. While some of the features of M2 differentiation, such as arginase-1 (murine) and 15-lipoxygenases (human and murine) expression, were also displayed by macrophages following the engulfment of apoptotic cells, it was not clear whether apoptotic cells can be regarded as an M2-like differentiating signal. In this manuscript we review the recent information regarding the impact of apoptotic cells on macrophage phenotype changes in molecular terms. We will focus on recent evidence for the in vivo existence of distinct pro-resolving macrophages and the role of apoptotic cells, specialized lipid mediators, and glucocorticoids in their generation. Consequently, we will suggest that these pro-resolving CD11blow macrophages have metamorphed from M2-like macrophages, and modulated their protein profile to accommodate the changes in their function.

1 January 2011 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
HSHaim Shapiro
Haim Shapiro
ALAviv Lutaty
Aviv Lutaty
AAAmiram Ariel
Amiram Ariel
Current research depicts specific modes of immunity and energy metabolism as being interrelated at the molecular, cellular, organ and organism level. Hence, whereas M2 (alternatively-activated) macrophages dominate insulin-sensitive adipose tissue in the lean, M1-skewed (classically-activated) macrophages accumulate in parallel to adiposity in the obese, and promote inflammation and insulin resistance, that is, meta-inflammation. The latest frontier of immuno-metabolism explores the coregulation of energy metabolism and immune function within hematopoietic cells. M1-skewed macrophages are sustained in edematous, hypoxic tissues by anaerobic glycolysis, whereas mitochondrial biogenesis and respiration dominates in M2 cells. We review the underlying mechanisms and the consequences of the transition from M2 to M1 predominance in adipose tissue, as well as the extracellular signals and transcription factors that control macrophage phenotypes and impose distinct metabolic modes.

12 December 2012 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
AAAmiram Ariel
Amiram Ariel
OTOrly Timor
Orly Timor